The Medical Devices Reimbursement Market is estimated at US$673.2 billion in 2026 and is projected to grow at a CAGR of 2.6% to reach US$826.7 billion by 2034.
Market expansion is supported by payer scrutiny, policy shifts, and the need to align innovation with coverage expectations. Even so, participants must navigate fragmented payer policies, evidence burdens, and evolving coding rules.
This product will be delivered within 1-3 business days.
Market Overview
The Medical Devices Reimbursement Market covers reimbursement support, coding, coverage strategy, and payment pathway advisory for medical device commercialization.Market expansion is supported by payer scrutiny, policy shifts, and the need to align innovation with coverage expectations. Even so, participants must navigate fragmented payer policies, evidence burdens, and evolving coding rules.
Market Segmentation
By Payer Type
- Public / Government
- Private / Commercial
- Self-pay / Out-of-pocket
By Device Category
- Diagnostic Imaging Devices
- Cardiovascular Devices
- Orthopedic Devices
- In-Vitro Diagnostics (IVD)
- Surgical Instruments
- Digital Health & Wearables
- Others
By End User
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Home-Healthcare Providers
- Medical Device Manufacturers
Key Companies Analysed
- IQVIA
- McKesson
- Optum
- Change Healthcare
- R1 RCM
- Cognizant
- Accenture
- Genpact
- Wipro
- Infosys
- HCLTech
- Cerner
- Athenahealth
- eClinicalWorks
- AGS Health
- GeBBS Healthcare
- Omega Healthcare
- Conifer Health
- NTT Data
- Deloitte
Geographic Coverage
- North America - Market data and outlook to 2034
- United States
- Canada
- Mexico
- Europe - Market data and outlook to 2034
- Germany
- United Kingdom
- France
- Italy
- Spain
- Netherlands
- Switzerland
- Poland
- Sweden
- Russia
- Asia-Pacific - Market data and outlook to 2034
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Malaysia
- Vietnam
- Middle East and Africa - Market data and outlook to 2034
- Saudi Arabia
- South Africa
- Iran
- UAE
- Egypt
- South and Central America - Market data and outlook to 2034
- Brazil
- Argentina
- Chile
- Peru
Report Delivery and Support
- Updated PDF report and an MS Excel workbook containing market tables and figures.
- 7-day post-sale analyst support for clarifications and in-scope supplementary data.
- Complimentary report update covering the latest available data and relevant market developments.
This product will be delivered within 1-3 business days.
Table of Contents
1. Contents and Report Guide
2. Global Medical Devices Reimbursement Market Overview
3. Medical Devices Reimbursement Market Dynamics
4. Medical Devices Reimbursement Market Strategic Analysis
5. Global Medical Devices Reimbursement Market Size, Share and Forecast, 2025-2034
6. North America Medical Devices Reimbursement Market Outlook to 2034
7. Europe Medical Devices Reimbursement Market Outlook to 2034
8. Asia-Pacific Medical Devices Reimbursement Market Outlook to 2034
9. Middle East and Africa Medical Devices Reimbursement Market Outlook to 2034
10. South and Central America Medical Devices Reimbursement Market Outlook to 2034
11. Medical Devices Reimbursement Market Competitive Landscape
12. Appendix
Companies Mentioned
- IQVIA
- McKesson
- Optum
- Change Healthcare
- R1 RCM
- Cognizant
- Accenture
- Genpact
- Wipro
- Infosys
- HCLTech
- Cerner
- Athenahealth
- eClinicalWorks
- AGS Health
- GeBBS Healthcare
- Omega Healthcare
- Conifer Health
- NTT Data
- Deloitte
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 160 |
| Published | October 2026 |
| Forecast Period | 2026 - 2034 |
| Estimated Market Value ( USD | $ 673.2 Billion |
| Forecasted Market Value ( USD | $ 826.7 Billion |
| Compound Annual Growth Rate | 2.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 20 |
